BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15664815)

  • 1. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.
    Angeli A; Chiaramonte N; Manetti D; Romanelli MN; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):303-308. PubMed ID: 29280407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors-A New Drug Targeting Approach.
    Bache M; Heise NV; Thiel A; Funtan A; Seifert F; Petrenko M; Güttler A; Brandt S; Mueller T; Vordermark D; Thondorf I; Csuk R; Paschke R
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Two Different Drugs Used in Alzheimer's Disease Treatment on Human Carbonic Anhydrase Isozymes I and II Activity: an
    DiLEK E
    Turk J Pharm Sci; 2017 Aug; 14(2):164-168. PubMed ID: 32454608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Feedback Inhibition Influences Metabolite Secretion by the Human Gut Symbiont Bacteroides thetaiotaomicron.
    Catlett JL; Catazaro J; Cashman M; Carr S; Powers R; Cohen MB; Buan NR
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32873608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII.
    Meleddu R; Distinto S; Cottiglia F; Angius R; Caboni P; Angeli A; Melis C; Deplano S; Alcaro S; Ortuso F; Supuran CT; Maccioni E
    ACS Med Chem Lett; 2020 May; 11(5):852-856. PubMed ID: 32435395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic Anhydrases: Role in pH Control and Cancer.
    Mboge MY; Mahon BP; McKenna R; Frost SC
    Metabolites; 2018 Feb; 8(1):. PubMed ID: 29495652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
    Riemann A; Güttler A; Haupt V; Wichmann H; Reime S; Bache M; Vordermark D; Thews O
    Oncol Res; 2018 Mar; 26(2):191-200. PubMed ID: 28631600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.
    Sedlakova O; Svastova E; Takacova M; Kopacek J; Pastorek J; Pastorekova S
    Front Physiol; 2014 Jan; 4():400. PubMed ID: 24409151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.
    Martin DP; Cohen SM
    Chem Commun (Camb); 2012 May; 48(43):5259-61. PubMed ID: 22531842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T tubules and surface membranes provide equally effective pathways of carbonic anhydrase-facilitated lactic acid transport in skeletal muscle.
    Hallerdei J; Scheibe RJ; Parkkila S; Waheed A; Sly WS; Gros G; Wetzel P; Endeward V
    PLoS One; 2010 Dec; 5(12):e15137. PubMed ID: 21179203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet.
    Rusconi S; Innocenti A; Vullo D; Mastrolorenzo A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5763-7. PubMed ID: 15501037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
    Pastorekova S; Parkkila S; Pastorek J; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates.
    Innocenti A; Vullo D; Scozzafava A; Casey JR; Supuran C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):573-8. PubMed ID: 15664815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(3):567-71. PubMed ID: 15664814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides.
    Innocenti A; Antel J; Wurl M; Vullo D; Firnges MA; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1909-13. PubMed ID: 15780631
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.